Mechanical support for acutely failed heart or lung grafts

Journal of Cardiac Surgery

Volumn 15, Issue 2, 2000, Pages 129-135

  Miniati, Douglas N ^a   Robbins, Robert C ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

ACUTE DISEASE; ALLOGRAFT; ARTICLE; ARTIFICIAL VENTILATION; BLEEDING; CONCENTRATION RESPONSE; DEATH; EXTRACORPOREAL OXYGENATION; GRAFT FAILURE; HEART GRAFT; HEART LUNG TRANSPLANTATION; HUMAN; INTENSIVE CARE; NEUROLOGIC DISEASE; PATIENT MONITORING; PULMONARY HYPERTENSION; RISK FACTOR; SURVIVAL;

ASSISTED CIRCULATION; EXTRACORPOREAL MEMBRANE OXYGENATION; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; LUNG; NITRIC OXIDE;

EID: 0034449142     PISSN: 08860440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Hosenpud JD, Bennett LE, Keck BM, et al: The Registry of the International Society for Heart and Lung Transplantation: Fifteenth official report - 1998. J Heart Lung Transplant 1998;17:656-668.
2. 2. Kanter KR, Pennington DG, McBride LR, et al: Mechanical circulatory assistance after heart transplantation. J Heart Transplant 1987;6:150-154.
3. 3. Radovancevic B, Nakatani T, Frazier OH, et al: Mechanical circulatory support for perioperative donor heart failure. ASAIO Trans 1989;35:539-541.
4. 4. Deeb GM, Bolling SF, Nicklas J, et al: Clinical experience with the Nimbus pump. ASAIO Trans 1990;36:M632-M636.
5. 5. Baldwin RT, Radovancevic B, Duncan JM, et al: Quality of life in long-term survivors of the Hemopump left ventricular assist device, ASAIO Trans 1991;37:M422-M423.
6. 6. Pifarre R, Sullivan H, Montoya A, et al: Use of the total artificial heart and ventricular assist device as a bridge to transplantation. J Heart Transplant 1990;9:638-642.
7. 7. Jaggers J, Fullerton DA, Campbell DN, et al: Cardiac allograft failure: Successful use of biventricular assist device. Ann Thorac Surg 1995;60:1409-1411.
8. 8. Fernandez AL, Herreros JM, Llorens R, et al: Primary graft failure after heart transplantation. Successful recovery with pneumatic biventricular assistance. Int J Artif Organs 1996;19:307-310.
9. 9. Tenderich G, Koerner MM, Stuettgen B, et al: Mechanical circulatory support after orthotopic heart transplantation. Int J Artif Organs 1998;21:414-416.
10. 10. Icenogle TB, Williams RJ, Smith RG, et al: Extracorporeal pulsatile biventricular support after cardiac transplantation. Ann Thorac Surg 1989;47:614-616.
11. 11. Ott RA, Mills T, Allen B, et al: Successful treatment of acute allograft failure using pneumatic biventricular assistance. J Heart Lung Transplant 1991; 10:264-268.
12. 12. Seifert PE, Auer JE, Hazelrigg SR: Successful double bridge to transplantation with the Thoratec ventricular assist device. J Heart Lung Transplant 1992;11:812-814.
13. 13. Esmore DS, Spratt PM, Branch JM, et al: Right ventricular assist and prostacyclin infusion for allograft failure in the presence of high pulmonary vascular resistance. J Heart Transplant 1990;9:136-141.
14. 14. Hooper TL, Odom NJ, Fetherston GJ, et al: Successful use of left ventricular assist device for primary graft failure after heart transplantation. J Heart Transplant 1988;7:385-387.
15. 15. Palmer RM, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327:524-526.
16. 16. Ignarro LJ, Buga GM, Wood KS, et al: Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A 1987;84:9265-9269.
17. 17. Meyer KC, Love RB, Zimmerman JJ: The therapeutic potential of nitric oxide in lung transplantation. Chest 1998;113:1360-1371.
18. 18. Toledo-Pereyra LH, Hau T, Simmons RL, et al: Lung preservation techniques. Ann Thorac Surg 1977;23:487-494.
19. 19. Wessel DL, Adatia I, Giglia TM, et al: Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation 1993;88: 2128-2138.
20. 20. Turner-Gomes SO, Andrew M, Coles J, et al: Abnormalities in von Willebrand factor and antithrombin III after cardiopulmonary bypass operations for congenital heart disease. J Thorac Cardiovasc Surg 1992;103:87-97.
21. 21. Date H, Triantafillou AN, Trulock EP, et al: Inhaled nitric oxide reduces human lung allograft dysfunction. J Thorac Cardiovasc Surg 1996;111:913-919.
22. 22. Kemming GI, Merkel MJ, Schallerer A, et al: Inhaled nitric oxide (NO) for the treatment of early allograft failure after lung transplantation. Munich Lung Transplant Group. Intensive Care Med 1998;24:1173-1180.
23. 23. Adatia I, Lillehei C, Arnold JH, et al: Inhaled nitric oxide in the treatment of postoperative graft dysfunction after lung transplantation. Ann Thorac Surg 1994;57:1311-1318.
24. 24. Kieler-Jensen N, Lundin S, Richsten SE: Vasodilator therapy after heart transplantation: Effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside. J Heart Lung Transplant 1995;14:436-443.
25. 25. Girard C, Durand PG, Vedrinne C, et al: Case 4-1993. Inhaled nitric oxide for right ventricular failure after heart transplantation [see Comments]. J Cardiothorac Vasc Anesth 1993;7:481-485.
26. 26. Carrier M, Blaise G, Belisle S, et al: Nitric oxide inhalation in the treatment of primary graft failure following heart transplantation. J Heart Lung Transplant 1999;18:664-667.
27. 27. George SJ, Boscoe MJ: Inhaled nitric oxide for right ventricular dysfunction following cardiac transplantation. Br J Clin Pract 1997;51:53-55.
28. 28. Radi R, Beckman JS, Bush KM, et al: Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem 1991;266: 4244-4250.
29. 29. Radi R, Beckman JS, Bush KM, et al: Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 1991;288:481-487.
30. 30. Radi R, Rodriguez M, Castro L, et al: Inhibition of mitochondrial electron transport by peroxynitrite, Arch Biochem Biophys 1994;308:89-95.
31. 31. King PA, Jamison E, Strahs D, et al: "Footprinting" proteins on DNA with peroxonitrous acid. Nucleic Acids Res 1993;21:2473-2478.
32. 2. Arc Environ Health 1972;24:180-188.
33. 33. Berlett BS, Friguet B, Yim MB, et al: Peroxynitrite-mediated nitration of tyrosine residues in Escherichia coli glutamine synthetase mimics adenylylation: Relevance to signal transduction. Proc Natl Acad Sci U S A 1996;93:1776-1780.
34. 34. Pryor WA, Squadrito GL: The chemistry of peroxynitrite: A product from the reaction of nitric oxide with superoxide [see Comments]. Am J Physiol 1995;268:L699-L722.
35. 35. Szabo C: The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury. Shock 1996;6:79-88.
36. 36. Frostell C, Fratacci MD, Wain JC, et al: Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction [published Erratum appears in Circulation 1991;84: 2212]. Circulation 1991;83:2038-2047.
37. 36. Frostell C, Fratacci MD, Wain JC, et al: Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction [published Erratum appears in Circulation 1991;84:2212]. Circulation 1991;83:2038-2047.
38. 37. Scott EM: Genetic disorders in isolated populations. Arch Environ Health 1973;26:32-35.
39. 38. Williams TJ, Salamonsen RF, Snell G, et al: Preliminary experience with inhaled nitric oxide for acute pulmonary hypertension after heart transplantation. J Heart Lung Transplant 1995;14:419-423.
40. 39. Nelems JM, Duffin J, Glynn FX, et al: Extracorporeal membrane oxygenator support for human lung transplantation. J Thorac Cardiovasc Surg 1978;76:28-32.
41. 40. Galantowicz ME, Stolar CJ: Extracorporeal membrane oxygenation for perioperative support in pediatric heart transplantation. J Thorac Cardiovasc Surg 1991;102:148-151.
42. 41. Slaughter MS, Nielsen K, Bolman RM: Extracorporeal membrane oxygenation after lung or heart-lung transplantation. ASAIO J 1993;39:M453-M456.
43. 42. Classman LR, Keenan RJ, Fabrizio MC, et al; Extracorporeal membrane oxygenation as an adjunct treatment for primary graft failure in adult lung transplant recipients. J Thorac Cardiovasc Surg 1995;110:723-726.
44. 43. Zenati M, Pham SM, Keenan RJ, et al: Extracorporeal membrane oxygenation for lung transplant recipients with primary severe donor lung dysfunction. Transplant Int 1996;9:227-230.
45. 44. Whyte RI, Deeb GM, McCurry KR, et al: Extracorporeal life support after heart or lung transplantation. Ann Thorac Surg 1994;58:754-758.
46. 45. Delius RE, Zwischenberger JB, Cilley R, et al: Prolonged extracorporeal life support of pediatric and adolescent cardiac transplant patients. Ann Thorac Surg 1990;50:791-795.
47. 46. Ball JWJ, Noon GP, Short HD, et al: Extracorporeal membrane oxygenation for early graft dysfunction in lung transplantation: A case report. J Heart Lung Transplant 1997;16:468-471.
48. 47. Aranki SF, Adams DH, Rizzo RJ, et al: Femoral venoarterial extracorporeal life support with minimal or no heparin. Ann Thorac Surg 1993;56:149-155.
49. 48. Barzaghi N, Olivei M, Minzioni G, et al: ECMO and inhaled nitric oxide for cardiopulmonary failure after heart retransplantation. Ann Thorac Surg 1997;63:533-535.
50. 49. Walmrath D, Schneider T, Pilch J, et al: Aerosolised prostacyclin in adult respiratory distress syndrome [see Comments]. Lancet 1993;342:961-962.
51. 50. Zwissler B, Welte M, Messmer K: Effects of inhaled prostacyclin as compared with inhaled nitric oxide on right ventricular performance in hypoxic pulmonary vasoconstriction. J Cardiothorac Vasc Anesth 1995;9:283-289.
52. 51. Haraldsson A, Kieler-Jensen N, Ricksten SE: Inhaled prostacyclin for treatment of pulmonary hypertension after cardiac surgery or heart transplantation: A pharmacodynamic study. J Cardiothorac Vasc Anesth 1996;10:864-868.
53. 52. Degraeuwe PL, Vos GD, Blanco CE: Perfluorochemical liquid ventilation: From the animal laboratory to the intensive care unit. Int J Artif Organs 1995;18:674-683.
54. 53. Itano H, Aoe M, Ichiba S, et al: Partial liquid ventilation for acute allograft dysfunction after canine lung transplantation. Ann Thorac Surg 1999;67:332-339.
55. 54. Auler JO, Carmona MJ, Bocchi EA, et al: Low doses of inhaled nitric oxide in heart transplant recipients. J Heart Lung Transplant 1996;15:443-450.